| P2093 | author name string | Virginia B Mattis | |
| | Clive N Svendsen | |
| P2860 | cites work | Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 | Q22337290 |
| | Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation | Q24297619 |
| | Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells | Q24632072 |
| | Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 |
| | Virus-free induction of pluripotency and subsequent excision of reprogramming factors | Q24644686 |
| | Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 |
| | Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 |
| | Establishment in culture of pluripotential cells from mouse embryos | Q27860625 |
| | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Embryonic stem cell lines derived from human blastocysts | Q27861010 |
| | The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein | Q28117885 |
| | A novel function for fragile X mental retardation protein in translational activation | Q28118268 |
| | Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 |
| | The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses | Q28208647 |
| | Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury | Q28250167 |
| | Human embryonic stem cells as models for aneuploid chromosomal syndromes | Q39678535 |
| | Stem cell biologists sure play a mean pinball | Q39716946 |
| | Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity | Q39717297 |
| | Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming | Q39727626 |
| | Efficient generation of mature cerebellar Purkinje cells from mouse embryonic stem cells | Q39808624 |
| | Human embryonic stem cell models of Huntington disease. | Q39830070 |
| | Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures | Q39830573 |
| | Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells | Q39910905 |
| | Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation | Q39910909 |
| | Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos | Q39997723 |
| | Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. | Q40188644 |
| | Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation | Q40493282 |
| | APOE is a major susceptibility gene for Alzheimer's disease | Q40535799 |
| | Aberrant A2A receptor function in peripheral blood cells in Huntington's disease | Q40564008 |
| | Induced pluripotent stem cell generation using a single lentiviral stem cell cassette | Q40721564 |
| | The neurobiology of childhood spinal muscular atrophy. | Q41489423 |
| | Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells | Q41884630 |
| | Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice | Q42513638 |
| | Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency | Q42811272 |
| | Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage | Q42943701 |
| | Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses | Q44092340 |
| | Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. | Q44306949 |
| | Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. | Q44591596 |
| | Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome | Q44959699 |
| | Generalized brain and skin proteasome inhibition in Huntington's disease | Q45045405 |
| | Specification of motoneurons from human embryonic stem cells. | Q45246951 |
| | Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells | Q45301722 |
| | Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice | Q46254778 |
| | Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells. | Q46481470 |
| | Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay | Q46686370 |
| | The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain | Q47070176 |
| | Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function | Q47071944 |
| | Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat | Q48255852 |
| | Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. | Q48373564 |
| | Efficient induction of oligodendrocytes from human embryonic stem cells | Q48391796 |
| | Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology | Q48552200 |
| | Analysis of neocortex in three males with the fragile X syndrome | Q48619801 |
| | Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells | Q48946379 |
| | Generation of cerebellar neuron precursors from embryonic stem cells. | Q50743270 |
| | Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. | Q50856695 |
| | Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. | Q51048666 |
| | Normal Neurogenesis but Abnormal Gene Expression in Human Fragile X Cortical Progenitor Cells. | Q51894563 |
| | Derivation of neural crest cells from human pluripotent stem cells. | Q51911549 |
| | DNA methylation represses FMR-1 transcription in fragile X syndrome | Q52042005 |
| | Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells | Q56768636 |
| | Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro | Q58187428 |
| | Pluripotent embryonic stem cell lines can be derived from tw5/tw5 blastocysts | Q59085970 |
| | Benefits of Utilizing Gene-Modified iPSCs for Clinical Applications | Q64965915 |
| | Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes | Q73775112 |
| | Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death | Q79807375 |
| | Human stem cells and drug screening: opportunities and challenges | Q83910679 |
| | Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression | Q28257629 |
| | Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts | Q28261807 |
| | Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 |
| | Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein | Q28273516 |
| | Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 |
| | Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy | Q28289793 |
| | Viable offspring derived from fetal and adult mammalian cells | Q28304072 |
| | Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells | Q28475963 |
| | Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons | Q28593320 |
| | Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors | Q28749672 |
| | Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 |
| | Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 |
| | Epigenetic memory in induced pluripotent stem cells | Q29547892 |
| | Induced pluripotent stem cells from a spinal muscular atrophy patient | Q29614340 |
| | Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 |
| | Induced pluripotent stem cells generated without viral integration | Q29614343 |
| | Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons | Q29616199 |
| | Directed differentiation of embryonic stem cells into motor neurons | Q29616200 |
| | Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 |
| | Somatic coding mutations in human induced pluripotent stem cells | Q29616798 |
| | Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 |
| | piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 |
| | A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells | Q29619964 |
| | Fragile X mental retardation protein controls trailer hitch expression and cleavage furrow formation in Drosophila embryos | Q30479193 |
| | Mouse models of Huntington's disease and methodological considerations for therapeutic trials | Q30481208 |
| | Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. | Q32063419 |
| | Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain | Q33281163 |
| | Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds | Q33382569 |
| | Chromosome 7 and 19 trisomy in cultured human neural progenitor cells | Q33515583 |
| | Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. | Q33612216 |
| | A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. | Q33637811 |
| | Stem cell-based neuroprotective and neurorestorative strategies | Q33910882 |
| | Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury | Q34004845 |
| | Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome | Q34018343 |
| | Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study | Q34112868 |
| | Direct conversion of human fibroblasts to multilineage blood progenitors. | Q34148584 |
| | Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. | Q34156273 |
| | Altered differentiation of neural stem cells in fragile X syndrome | Q34202047 |
| | Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability | Q34330367 |
| | FMR1 and the fragile X syndrome: human genome epidemiology review | Q34362009 |
| | Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome | Q34401155 |
| | The survival motor neuron protein in spinal muscular atrophy | Q34435656 |
| | Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells | Q34587918 |
| | Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture | Q34596358 |
| | The fragile X premutation: into the phenotypic fold | Q34699408 |
| | Genomic instability in induced stem cells | Q34816201 |
| | Variation in the safety of induced pluripotent stem cell lines | Q34991636 |
| | Stem cell model of spinal muscular atrophy | Q35119814 |
| | Pedigreed primate embryonic stem cells express homogeneous familial gene profiles | Q35170499 |
| | Human neural stem cells: a new tool for studying cortical development in Down's syndrome. | Q35204311 |
| | The unstable and methylatable mutations causing the fragile X syndrome | Q35221532 |
| | Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases | Q35645641 |
| | Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells | Q35966957 |
| | Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. | Q36545930 |
| | Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. | Q36677109 |
| | Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. | Q36954944 |
| | Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease | Q36956907 |
| | Reprogramming of murine and human somatic cells using a single polycistronic vector | Q37068363 |
| | Unraveling the role of defective genes in Parkinson's disease | Q37082022 |
| | A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration | Q37117718 |
| | Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules | Q37254921 |
| | Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. | Q37255219 |
| | Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model | Q37357643 |
| | Modeling early retinal development with human embryonic and induced pluripotent stem cells | Q37377238 |
| | Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. | Q37444336 |
| | Differentiation of spinal motor neurons from pluripotent human stem cells | Q37460845 |
| | Derivation of midbrain dopamine neurons from human embryonic stem cells | Q37493958 |
| | Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling | Q37579376 |
| | Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming | Q37628974 |
| | The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1. | Q38339977 |
| | Copy number variation and selection during reprogramming to pluripotency | Q39582693 |
| P433 | issue | 4 | |
| P304 | page(s) | 383-394 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Induced pluripotent stem cells: a new revolution for clinical neurology? | |
| P478 | volume | 10 | |